STOCK TITAN

Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Bio-Rad Laboratories, Inc. will report its financial results for Q4 and full year 2022 on February 16, 2023, post-market close. Management will host a conference call at 2 PM PT (5 PM ET) to discuss these results. Participants can dial 844-200-6205 in the U.S. or +1 929-526-1599 internationally, using access code: 143970. A live webcast will also be available on their website. Bio-Rad is recognized globally for developing and marketing life science and clinical diagnostic products, generating $2.9 billion in revenues as of 2021.

Positive
  • None.
Negative
  • None.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To participate, dial 844-200-6205 within the U.S. or +1 929-526-1599 outside the U.S., access code: 143970. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,200 employees worldwide and $2.9 billion in revenues in 2021. For more information, please visit bio-rad.com.

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad report its financial results for Q4 2022?

Bio-Rad will report its financial results for Q4 2022 on February 16, 2023.

What time is Bio-Rad's conference call regarding financial results?

The conference call will take place at 2 PM Pacific Time on February 16, 2023.

How can I access the Bio-Rad conference call?

You can dial 844-200-6205 from the U.S. or +1 929-526-1599 internationally, with access code: 143970.

What revenue did Bio-Rad generate in 2021?

Bio-Rad generated $2.9 billion in revenue in 2021.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

9.07B
19.42M
15.58%
78.32%
2.33%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
IRVINE